αS-SETMAR: Inducing Protective Chaos in Glioblastoma?

Overview

1. Université de Tours, INSERM, Imaging Brain & Neuropsychiatry, iBraiN U1253, 37032 Tours, France; (S.-A.D.); (S.B.); (O.L.); (A.D.); (J.J.); (M.G.)
2. TISSIUM (Tissue Reconstructing Solutions), 74 Rue du Faubourg Saint-Antoine, 75012 Paris, France

Abstract

Background/Objectives: Glioblastoma remains the most aggressive and lethal form of brain cancer, with no effective cure to date. The molecular mechanisms sustaining its development and relentless proliferation are still not fully understood. SETMAR, a protein lysine methyltransferase involved in various DNA repair and chromatin processes, has been reported as dysregulated in several cancers, including glioblastoma. Interestingly, S-SETMAR, a shorter isoform of SETMAR, has been suggested to antagonize the oncogenic properties of the full-length protein. Here, we explored the cellular and molecular consequences of S-SETMAR overexpression in glioblastoma cells. Methods: We compared native glioblastoma cells (8MGBA) with a recombinant 8MGBA line stably over-expressing αS-SETMAR, a stable form of S-SETMAR, using complementary cellular and molecular approaches. Results: Overexpression of αS-SETMAR markedly prolonged the cell cycle duration (from 27 to 37 h), leading to a significant decrease in cell proliferation. Unexpectedly, αS-SETMAR triggered genomic alterations characterized by an increased DNA content and extensive chromosomal instability, including aneuploidy, chromoanasynthesis-like rearrangements, and tripolar mitoses. Moreover, αS-SETMAR-expressing cells displayed heightened sensitivity to stress conditions mimicking chemotherapy and radiotherapy, resulting in increased apoptosis. Conclusions: Our findings identify αS-SETMAR as a dual modulator of glioblastoma cell fate—simultaneously slowing proliferation and promoting chromosomal instability while enhancing vulnerability to genotoxic stress. These results suggest that αS-SETMAR could serve as both a prognostic marker and a potential therapeutic tool in glioblastoma management.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• geo:GSE255745, at NCBI GEO; found in “Data Availability Statement”

Data Availability Statement

Sequencing data have been deposited in GEO under accession number GSE255745 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255745). Time-lapse motions of both cell lines are available by clicking on the following link: https://osf.io/j84kd/?view_only=0df478d991db41a6b1c855a90e5cd0e7 (accessed on 17 October 2024).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 5 keywords, 2 funders, 40 references.

Cite

This paper

David, S.-A., Benharrat, S., Lié, O., Dufresne, A., Jaillet, J., Genty, M., Renault, S., & Augé-Gouillou, C. (2026). αS-SETMAR: Inducing Protective Chaos in Glioblastoma? Cancers, 18(13), 2151. https://doi.org/10.3390/cancers18132151

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1002/adhm.202504889 [code]

Mapping the Cerebral Organoid Landscape: A Systematic Review of Preclinical 3D Models in Neuroscience.

Journal: Advanced healthcare materials

In common: other condition, 1 reference

[2] doi:10.3390/ijms27167240

1-Piperidine Propionic Acid Inhibits PAR2/SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness.

Journal: International journal of molecular sciences

In common: other condition, 1 reference

[3] doi:10.1038/s41467-026-72746-5

Non-lytic viral immunotherapy induces long-term glioblastoma survival and tumor-specific immunity without eliciting an antiviral response.

Journal: Nature communications

In common: other condition, 1 reference

[4] doi:10.1371/journal.pone.0349101

Overexpression of key complement regulators in glioblastoma.

Journal: PloS one

In common: other condition, 1 reference

[5] doi:10.1038/s41598-026-48666-1 [code]

Multimodal survival analysis of glioblastoma using whole-slide histopathology, gene expression, clinical variables and language-model-derived mutation features.

Journal: Scientific reports

In common: other condition, 1 reference

[6] doi:10.1111/acel.70494

Exceptional Longevity Modifying Allele APOE2 Promotes DNA Signaling Pathways Resisting Cellular Senescence in Human Neurons.

Journal: Aging cell

In common: 1 reference

[7] doi:10.1016/j.nbd.2026.107379 [code]

DYRK1A and Parkinson's disease, facts and hypotheses.

Journal: Neurobiology of disease

In common: 1 reference

[8] doi:10.1016/j.isci.2026.116660

Development of an <i>in vivo</i>, screenable, split-luciferase based model of huntingtin multimerization.

Journal: iScience

In common: other condition, 1 reference

[9] doi:10.7554/elife.107085 [code]

Activity-dependent CO<sub>2</sub> production in the axon triggers opening of Connexin32 in the Schwann cell paranode.

Journal: eLife

In common: other condition, 1 reference

[10] doi:10.1038/s41586-026-10641-1 [code]

Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cells.

Journal: Nature

In common: other condition, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.